Grants per year
Search results
-
Active
Prot #0610-02: A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET Proteins: Phase 1 (Dose Escalation of CPI-0610 in Patients with Hematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 with and without Ruxolitinib in Patients wi
Stein, B. L. (PD/PI)
Parexel, Constellation Pharmaceuticals, Inc.
10/2/18 → 10/2/24
Project: Research project